Immunologic defect may leave some vulnerable to rare bacterial infection
LA JOLLA, CA—Everyone breathes in Mycobacterium avium complex (MAC) bacteria from time to time, but most people don’t get sick.
Discovering mechanisms of host cellular remodeling by viral pathogens with quantitative proteomics
Jeffery Johnson, PhD. Associate Professor, Icahn School of Medicine at Mount Sinai, Department of Microbiology
PD-L1/PD-1 Cancer Immunotherapy and New Targets
Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School Host: Patrick Hogan
The longer the bootcamp, the better the antibodies
LJI scientists test new vaccine strategy to help the body target HIV
Richard S. Bodman and Fred Miller join LJI Board of Directors
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) has welcomed Richard S. Bodman and Fred Miller to the Institute’s Board
How human cells become Zika virus factories
LJI scientists uncover major clue toward developing a pan-flavivirus therapy
The scientific visual storyteller
"Microscopy helps create an ideal canvas to illustrate how the many types of immune cells work together"
Sequencing specialist Hannah Dose wins XPRIZE-funded fellowship
Why a cutting-edge COVID-19 testing protocol was just the beginning
Asthma researcher Sara Herrera de la Mata wins BioLegend Graduate Fellowship in Immunology
Herrera de la Mata aims to understand how asthma turns deadly
Can your macrophages ‘smell’ infections?
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Instructor Marco Orecchioni, Ph.D., has shown that olfactory receptors are important for
The gut patrol
A fascinating new look at what drives T cells to guard the intestines
The life of a scientist studying Zika and dengue
Inside the work of immunologist Julia Timis